Invention Grant
- Patent Title: Use of a HIV derived accessory protein for the reactivation of latent HIV
-
Application No.: US16460872Application Date: 2019-07-02
-
Publication No.: US11098085B2Publication Date: 2021-08-24
- Inventor: Daniel Boden
- Applicant: Janssen Sciences Ireland Unlimited Company
- Applicant Address: IE County Cork
- Assignee: Janssen Sciences Ireland Unlimited Company
- Current Assignee: Janssen Sciences Ireland Unlimited Company
- Current Assignee Address: IE County Cork
- Priority: EP14165811 20140424
- Main IPC: C07K14/005
- IPC: C07K14/005 ; A61K38/16 ; A61K45/06
Abstract:
The present invention concerns the use of a protein comprising at least a HIV-derived accessory protein tat (trans-activator of transcription) or any derivative thereof for the reactivation of latent human immunodeficiency virus (HIV) from cells present in a HIV-infected patient.
Public/Granted literature
- US20190337992A1 Use of a HIV derived accessory protein for the reactivation of latent HIV Public/Granted day:2019-11-07
Information query
